Bruker Daltonics · 6 days ago
Scientist
Bruker Daltonics is one of the world’s leading analytical instrumentation companies enabling scientists to make breakthrough discoveries. They are seeking a highly motivated Computational Biologist II / Biostatistician II / Bioinformatics Scientist II to tackle research and development challenges related to deep learning models and statistical methods in a collaborative setting.
Biotechnology
Responsibilities
Training deep learning models on both transcriptomic and protein imaging data
Developing new statistical and computational methods
Creating and contributing to open-source software tools
Collaborating with cross-functional teams of biologists, assay developers, and software engineers
Qualification
Required
PhD in Computational Biology, Biostatistics, Bioinformatics, Computer Science, or a related field (new graduates welcome)
Demonstrated expertise in neural network training as a major part of your research or applied work
Strong programming skills in Python and/or R
Preferred
Familiarity with single-cell or spatial omics data
Some expertise in cancer biology, neuroscience or cellular biology
Experience contributing to open-source projects
Benefits
401(k) with company match
Employee stock purchase plan
Medical and dental plans
Life insurance
Short-term and long-term disability insurance
Employee assistance program
Paid time off including vacation, sick time and holidays
Company
Bruker Daltonics
Bruker Life Science Mass Spectrometry is a leading global developer and manufacturer of innovative scientific instruments that address the rapidly evolving needs of a diverse array of life sciences customers.
H1B Sponsorship
Bruker Daltonics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2023 (1)
2022 (2)
Funding
Current Stage
Late StageCompany data provided by crunchbase